Symptomatic form of Coffin-Lowry syndrome in female carriers

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:276630OMIM:300844Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

The symptomatic form of Coffin-Lowry syndrome in female carriers refers to the clinical manifestations that can occur in heterozygous females who carry a pathogenic variant in the RPS6KA3 gene on the X chromosome. While Coffin-Lowry syndrome (CLS) classically presents as a severe condition in affected males, female carriers can exhibit a wide spectrum of symptoms due to variable X-chromosome inactivation (lyonization). This condition is also referred to as manifesting carrier status for Coffin-Lowry syndrome. Female carriers may display milder but clinically significant features affecting multiple body systems. Key manifestations can include mild to moderate intellectual disability or learning difficulties, characteristic facial features (such as a prominent brow, wide nose with thick nasal septum, and full lips), short stature, and skeletal abnormalities including tapering or puffy fingers. Some carrier females may experience stimulus-induced drop attacks (sudden episodes of collapse triggered by unexpected stimuli such as touch or sound), which are a well-recognized feature of CLS. Cardiac involvement, including mitral valve prolapse, has also been reported in some carriers. The severity of symptoms varies considerably among affected females, ranging from very mild features that may go unrecognized to presentations approaching the severity seen in affected males. There is currently no cure or disease-specific treatment for the symptomatic form of Coffin-Lowry syndrome in female carriers. Management is supportive and symptom-based, including educational support for learning difficulties, physical and occupational therapy, orthopedic management for skeletal issues, and neurological monitoring for drop attacks. Anticonvulsant medications such as clonazepam or valproate may be considered for stimulus-induced drop episodes. Genetic counseling is important for carrier females regarding recurrence risks in future pregnancies.

Clinical phenotype terms— hover any for plain English:

AnodontiaHP:0000674Bipolar affective disorderHP:0007302
Inheritance

X-linked dominant

Carried on the X chromosome; a single copy can cause the condition

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Symptomatic form of Coffin-Lowry syndrome in female carriers.

View clinical trials →

No actively recruiting trials found for Symptomatic form of Coffin-Lowry syndrome in female carriers at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Symptomatic form of Coffin-Lowry syndrome in female carriers community →

No specialists are currently listed for Symptomatic form of Coffin-Lowry syndrome in female carriers.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Symptomatic form of Coffin-Lowry syndrome in female carriers.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Symptomatic form of Coffin-Lowry syndrome in female carriersForum →

No community posts yet. Be the first to share your experience with Symptomatic form of Coffin-Lowry syndrome in female carriers.

Start the conversation →

Latest news about Symptomatic form of Coffin-Lowry syndrome in female carriers

No recent news articles for Symptomatic form of Coffin-Lowry syndrome in female carriers.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Symptomatic form of Coffin-Lowry syndrome in female carriers

What is Symptomatic form of Coffin-Lowry syndrome in female carriers?

The symptomatic form of Coffin-Lowry syndrome in female carriers refers to the clinical manifestations that can occur in heterozygous females who carry a pathogenic variant in the RPS6KA3 gene on the X chromosome. While Coffin-Lowry syndrome (CLS) classically presents as a severe condition in affected males, female carriers can exhibit a wide spectrum of symptoms due to variable X-chromosome inactivation (lyonization). This condition is also referred to as manifesting carrier status for Coffin-Lowry syndrome. Female carriers may display milder but clinically significant features affecting mul

How is Symptomatic form of Coffin-Lowry syndrome in female carriers inherited?

Symptomatic form of Coffin-Lowry syndrome in female carriers follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.